Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Februar 2023

Genmab — Februar 2023

Planlagt Fastgjort Låst Flyttet Genmab
713 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • StockBullS Offline
    StockBullS Offline
    StockBull
    wrote on sidst redigeret af
    #693

    Jamen jeg siger ikke Jan skal have mere end 8 mia. Kender som sagt ikke hans hyre for 2022 men vil mene en hyre ca. 50% under Novos CEO er ok. Så hvis Novo ligger på ca. 9 nu bør Jan ligge på
    ca.6.

    1 Reply Last reply
    0
    • StockBullS Offline
      StockBullS Offline
      StockBull
      wrote on sidst redigeret af
      #694

      Det kan man jo sige om alle de solide indikationer de har i pipelinen. Alle ved jo at under 10% kommer gennem nåleøjet. Men lige her har Genmab jo god track rekort med at vælge vinderne og stoppe med taberne i tide.

      1 Reply Last reply
      0
      • D Offline
        D Offline
        deleted-user
        wrote on sidst redigeret af
        #695

        Jan lægger på +40 mio. i 2022 og med en tabt voldgift i baggagen i årets l
        , så syns jeg det er voldsomt.

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #696

          ADC Therapeutics Reports Fourth Quarter and Full Year 2022 - Cami (camidanlumab tesirine)

          Based on the positive pivotal Phase 2 data, the Company is actively seeking a partner to progress this program.

          1 Reply Last reply
          0
          • D Offline
            D Offline
            deleted-user
            wrote on sidst redigeret af
            #697

            Voldsomt er måske "voldsomt" at bruge .... men det er hvert fald en flot løn, taget årets begivenheder in mente. Nuvel væksten er god, men voldgiften har potentialet kostet 12-13 % af +100-120 mia. kr. Mindes ikke Novo nogensinde har leveret samme streg i regningen

            1 Reply Last reply
            0
            • D Offline
              D Offline
              deleted-user
              wrote on sidst redigeret af
              #698

              Så tror jeg, at jeg har udtrykt mig til strækkeligt om lønninger og det forhold, at øget (US) lønniveau ikke er en nødvendig forudsætning for, at tiltrække dygtige medarbejdere og skabe store succes. Slut herfra, for i dag 🙂

              1 Reply Last reply
              0
              • StockBullS Offline
                StockBullS Offline
                StockBull
                wrote on sidst redigeret af
                #699

                Ja ok der mener jeg så en CEO skal måles på de resultater der kommer i hus og ikke den som fejler af den ene eller anden grund. Kurs stigning på +18% i snit sinde 2015 er ok og slutter i over 3400kr i år er det 8 år i træk. Over and out

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #700

                  Den tabte voldgift må JW tage sin del af æren for. Lad os få afgørelsen og se om vi er fortabte. Det burde få ham til at være lidt ydmyg, hvis den nuværende voldgift tabes.

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #701

                    3rd red month in a row. Since the lows of 2011 we only once had 4 negative months in a row, at the end of 2017

                    1 Reply Last reply
                    0
                    • E Offline
                      E Offline
                      E_L
                      wrote on sidst redigeret af
                      #702

                      2021 started with 3 red months after which we nicely rallied from 1900 to 3100+ ; all green months. That lasted the whole summer though, so maybe we should start vacations early 😉

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        Pensionisten
                        wrote on sidst redigeret af
                        #703

                        I started 01.01.2023, 🙂

                        1 Reply Last reply
                        0
                        • G Offline
                          G Offline
                          gentogen
                          wrote on sidst redigeret af
                          #704

                          For the first time, we report a successful approach to the treatment of refractory anti-NMDAR encephalitis
                          using the fully human anti-CD20 monoclonal antibody ofatumumab, which serves as an important
                          reference for the treatment of autoimmune encephalitis. In our cases, satisfactory clinical outcomes were still observed in anti-NMDR encephalitis
                          while first-line therapy failed. Thus, the case report provides reference for new treatment options of
                          autoimmune encephalitis

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            gentogen
                            wrote on sidst redigeret af
                            #705

                            https://assets.researchsquare.com/files/rs-2565559/v1/44257c98-f5d5-4bf9-8fe2-f350845789d7.pdf?c=1676475873

                            1 Reply Last reply
                            0
                            • G Offline
                              G Offline
                              gentogen
                              wrote on sidst redigeret af
                              #706

                              Our Alem-Ofa dual-targeted immunotherapy study showed that it is an early example of a chemotherapy-free treatment option with several advantages even in the modern treatment era. First the treatment is of a limited and short duration of no longer than 4.5 months. Second, it was able to achieve rapid onset, deep and durable response; most patients needed no additional therapy in the next five years.

                              1 Reply Last reply
                              0
                              • G Offline
                                G Offline
                                gentogen
                                wrote on sidst redigeret af
                                #707

                                Link Preview Image
                                ScienceDirect

                                favicon

                                (www.sciencedirect.com)

                                1 Reply Last reply
                                0
                                • G Offline
                                  G Offline
                                  gentogen
                                  wrote on sidst redigeret af
                                  #708

                                  Alem-Ofa is effective in untreated CLL with ORR 98%, CR 48% and 60% bone marrow uMRD

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #709

                                    @gentogen this was from December - https://www.frontiersin.org/articles/10.3389/fneur.2020.602102/full - Dara competing with Ofa, wouldn't that be fun

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #710

                                      or better yet, surely they
                                      can be combined 😉

                                      1 Reply Last reply
                                      0
                                      • SolsenS Offline
                                        SolsenS Offline
                                        Solsen
                                        wrote on sidst redigeret af
                                        #711

                                        https://www.linkedin.com/posts/claus-johansen-729292_genmab-newtakeovertarget-tivdak-activity-7036295466224898049-VRdi?utm_source=share&utm_medium=member_ios Takeover target ?

                                        1 Reply Last reply
                                        0
                                        • BulderB Offline
                                          BulderB Offline
                                          Bulder
                                          wrote on sidst redigeret af
                                          #712

                                          Tak gentogen. Hjernebetændelse rammer 250.000 hvert år alene i usa https://www.hopkinsmedicine.org/health/conditions-and-diseases/encephalitis

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper